Two New Drug Combinations Win Approval as the First Treatment for an Aggressive Stomach and Esophageal Cancer
The FDA approved two Ziihera regimens as first-line treatment for HER2-positive advanced gastroesophageal cancer, plus two companion diagnostic tests.
Medical Daily ·